エピソード

  • What happened to HEMGENIX!? An update on gene therapy.
    2026/04/10

    CSL Behring just announced a global "stockout" of Hemgenix—what's happening, and what does it mean for patients? On this episode of BloodStream Podcast, we break down the news, launch our mini-series on plasma donation, and hear from Thomas Savage in our I'm Fine segment, sharing the highs, the lows, and the reality of living with a severe bleeding disorder.

    Pain, perseverance, and the lessons learned along the way give a rare, unfiltered glimpse into life behind the headlines—reminding us all that every treatment, every donation, and every day matters.

    Show Notes:

    I'm Fine is presented by @SanofiUS

    #bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy

    Presenting Sponsor:

    Takeda, visit bleedingdisorders.com to learn more.



    Subscribe:

    The BloodStream Podcast

    Connect with BloodStream Media:

    BloodStreamMedia.com

    BloodStream on Facebook

    BloodStream on X/Twitter

    BloodStream on Instagram

    BloodStream on LinkedIn

    BloodStream on TikTok

    続きを読む 一部表示
    34 分
  • Understanding Hemophilia A & B with Inhibitors: SEVENFACT in Focus
    2026/04/03

    In this special partnered episode of the BloodStream Podcast, hosts Patrick James Lynch and Amy Board speak with hematologist Dr. Tami Singleton about hemophilia A and B with inhibitors, a complex condition that changes how bleeding episodes are treated. Dr. Singleton explains what inhibitors are, why they develop, and how they impact clotting and everyday life for patients and families. The conversation also explores SEVENFACT, a recombinant factor VIIa bypassing agent, including how it works and what patients should know about dosing and treatment planning.


    Click here to learn more about SEVENFACT.

    続きを読む 一部表示
    41 分
  • 100 Years of vWD w/ Dr. Nathan Connell
    2026/03/27

    This year marks 100 years since von Willebrand disease (vWD) was first described, and on this episode of BloodStream we take a closer look at how far the field has come.

    Our beloved hosts, Patrick and Amy happily welcome Dr. Nathan Connell, hematologist and leading expert in bleeding disorders, for a conversation about the past, present, and future of vWD. Together they explore how our understanding of the condition has evolved since its discovery, the challenges that remain in diagnosis and care, and why awareness still matters for the millions of people worldwide living with vWD.

    From early clinical observations to modern treatment approaches, Dr. Connell reflects on the milestones that have shaped care over the last century—and what the next hundred years could hold.

    Plus, a preview of what's coming next on BloodStream as we approach World Hemophilia Day.

    Show Notes:

    Presenting Sponsor:

    Takeda, visit bleedingdisorders.com to learn more.

    Subscribe:

    The BloodStream Podcast

    Connect with BloodStream Media:

    BloodStreamMedia.com

    BloodStream on Facebook

    BloodStream on X/Twitter

    BloodStream on Instagram

    BloodStream on LinkedIn

    BloodStream on TikTok

    続きを読む 一部表示
    33 分
  • Psychosocial support and bye bye, BioMarin
    2026/03/13

    Bleeding disorders aren't just medical conditions — they're lived experiences shaped by resilience, community, and support. On this episode of BloodStream Podcast, Patrick James Lynch sits down with the WFH working group to explore why psychosocial care matters just as much as medicine and how human connections help people thrive.

    Rocky Williams joins to share the power of positivity and what it truly means to be more than "fine," inspiring the bleeding disorders community to dream bigger, aim higher, and embrace life fully. We also break down a major shift in gene therapy: BioMarin's decision to pull Roctavian from the market, what it means for patients, and why preserving critical clinical data is essential for ongoing research and safety.

    Tune in for a conversation that blends science, mindset, and community — because living with bleeding disorders is about more than treatments, it's about life itself.

    Show Notes:

    BioMarin pulls hemophilia gene therapy Roctavian

    WFH Gene Therapy Registry

    LevelsMatter.com

    Presenting Sponsor:

    Takeda, visit bleedingdisorders.com to learn more.

    I'm Fine is presented by @SanofiUS

    #bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy

    Subscribe:

    The BloodStream Podcast

    Connect with BloodStream Media:

    BloodStreamMedia.com

    BloodStream on Facebook

    BloodStream on X/Twitter

    BloodStream on Instagram

    BloodStream on LinkedIn

    BloodStream on TikTok

    続きを読む 一部表示
    48 分
  • Jeff & Barb with Connie Montgomery!
    2026/02/27

    On this episode of BloodStream, we're thrilled to sit down with Connie Montgomery alongside Jeff and Barb for a warm, wide-ranging conversation grounded in lived experience and deep community roots. Together, they reflect on the moments that shape advocacy, the evolution of the bleeding disorders space, and the power of staying connected to one another.

    Plus, a nod to Rare Disease Day, a bit of BloodStream banter, and a preview of what's ahead.

    Tune in, share with your community, and as always—take self-care of yourself.

    Presenting Sponsor:

    Takeda, visit bleedingdisorders.com to learn more.

    Subscribe:

    The BloodStream Podcast

    Connect with BloodStream Media:

    BloodStreamMedia.com

    BloodStream on Facebook

    BloodStream on X/Twitter

    BloodStream on Instagram

    BloodStream on LinkedIn

    BloodStream on TikTok

    続きを読む 一部表示
    31 分
  • A preview of 2026 World Congress with Dr. Glenn Pierce
    2026/02/20

    On this episode of BloodStream, we get a sneak peek at the 2026 World Congress with Dr. Glenn Pierce, Vice President, Medical at the World Federation of Hemophilia. What conversations are shaping the agenda? Where is the science heading? And how does a global convening like World Congress moves the needle on access, equity, and innovation for people living with bleeding disorders? Dr. Pierce shares why this gathering still matters — and what the community should be watching as 2026 approaches.

    Plus, in I'm Fine, we sit down with Anthony, a performer and educator living with a bleeding disorder. From invisible disability to grieving the life you imagined, it's a candid conversation about ambition, identity, and learning to stop blaming yourself for what you can't control.

    Global outlook. Personal reckoning. Classic BloodStream.

    Presenting Sponsor:

    Takeda, visit bleedingdisorders.com to learn more.

    I'm Fine is presented by @SanofiUS

    Subscribe:

    The BloodStream Podcast

    Connect with BloodStream Media:

    BloodStreamMedia.com

    BloodStream on Facebook

    BloodStream on X/Twitter

    BloodStream on Instagram

    BloodStream on LinkedIn

    BloodStream on TikTok

    続きを読む 一部表示
    33 分
  • ASH 2025 Highlights
    2026/02/13

    ASH 2025 brought a wave of new data — and on this episode, we're digging into what stood out.

    Patrick and Amy welcome Dr. Akshat Jain to talk through the research, the momentum in hematology, and the conversations coming out of this year's meeting. What's generating excitement? What feels meaningful? And what could shape care moving forward for the bleeding disorders community?

    If ASH sets the tone for the year ahead, this is your chance to hear how it's sounding.

    Presenting Sponsor:

    Takeda, visit bleedingdisorders.com to learn more.

    Subscribe:

    The BloodStream Podcast

    Connect with BloodStream Media:

    BloodStreamMedia.com

    BloodStream on Facebook

    BloodStream on X/Twitter

    BloodStream on Instagram

    BloodStream on LinkedIn

    BloodStream on TikTok

    続きを読む 一部表示
    39 分
  • Amy's History in Hemophilia
    2026/01/23

    Patrick and Amy sit down to hear her story—how she first got involved in the bleeding disorders community back in 2003, and how patient advocacy became her passion. Along the way, they share laughs about their unexpected pasts as actors and the moments that shaped their paths.

    Also on this episode of BloodStream, our hosts also look back on the year in gene therapy, spotlighting patients, clinicians, and researchers who are redefining what's possible, including five-year insights from the HOPE-B study in hemophilia B.

    This episode is a celebration of hope, trust, and progress—a reminder that hemophilia care isn't just about science, it's about people and the possibilities they create.

    Presenting Sponsor:

    Takeda, visit bleedingdisorders.com to learn more.

    It's a Whole New World brought to you by @CSLBehring.

    #bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #genetherapy #healthcare #digitalhealth #biotech

    Show Notes:

    Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B

    https://www.nejm.org/doi/full/10.1056/NEJMoa2514332

    Subscribe:

    The BloodStream Podcast

    Connect with BloodStream Media:

    BloodStreamMedia.com

    BloodStream on Facebook

    BloodStream on X/Twitter

    BloodStream on Instagram

    BloodStream on LinkedIn

    BloodStream on TikTok

    続きを読む 一部表示
    38 分